Claims
- 1. A composition comprising an adjuvant selected from the group consisting of E. coli heat-labile toxin (LT) and E. coli heat-labile toxin analogs (LT analogs) for use in vaccinating a bird.
- 2. The composition of claim 1 further comprising an immunoprotective antigen effective in a bird.
- 3. The composition of claim 2 wherein the immunoprotective antigen is derived from the group consisting of a viral, bacterial, or fungal pathogen.
- 4. The composition of claim 3 wherein the immunoprotective antigen is selected from the group consisting of known immunoprotective antigens of Newcastle disease, avain influenza, infectious bursal disease, coccidiosis, necrotic enteritis, airsacculitis, cellulitis, chicken anemia, larygnorhinotracheitis, infectious bronchitis, and Marek's disease.
- 5. The composition of claim 4 wherein the immunoprotective antigen is selected from the group consisting of Newcastle disease virus hemaglutinin neuraminidase protein and avian influenza hemagglutinin protein.
- 6. The composition of claim 1 wherein the adjuvant is produced by an E. coli bacterium.
- 7. The composition of claim 1 wherein the adjuvant is produced by a transgenic plant.
- 8. The composition of claim 2 wherein the immunoprotective antigen is produced in a transgenic plant.
- 9. The composition of claim 2 wherein the adjuvant and the immunoprotective antigen are produced in a transgenic plant.
- 10. The composition of claim 2 wherein the adjuvant and the immunoprotective antigen are produced in a single transgenic plant.
- 11. A method for vaccinating a bird comprising administering an effective amount of the composition of claim 1.
- 12. A method for vaccinating a bird comprising administering an effective amount of the composition of claim 2.
- 13. A method for vaccinating a bird comprising administering an effective amount of the composition of claim 3.
- 14. A method for vaccinating a bird comprising administering an effective amount of the composition of claim 4.
- 15. A method for vaccinating a bird comprising administering an effective amount of the composition of claim 5.
- 16. A method for preparing a vaccine for protecting a bird against an avian disease which comprises mixing an effective amount native LT with an effective amount of an immunoprotective antigen known to elicit an immune response in a bird.
- 17. A method for preparing a vaccine for protecting a bird against an avian disease which comprises mixing an effective amount LT analog with an effective amount of an immunoprotective antigen known to elicit an immune response in a bird.
- 18. The method of claim 16 wherein the immunoprotective antigen is selected from the group consisting of known immunoprotective antigens of Newcastle disease, avain influenza, infectious bursal disease, coccidiosis, necrotic enteritis, airsacculitis, cellulitis, chicken anemia, larygnorhinotracheitis, infectious bronchitis, and Marek's disease.
- 19. The method of claim 16 wherein the immunoprotective antigen is selected from the group consisting of Newcastle disease virus hemaglutinin neuraminidase protein and avian influenza hemagglutinin protein.
- 20. The method of claim 16 wherein the immunoprotective antigen is the Newcastle disease virus hemaglutinin neuraminidase protein.
Parent Case Info
[0001] This application claims priority to U.S. Provisional Docket Number 60/406,359 filed Aug. 27, 2002.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60406359 |
Aug 2002 |
US |